The Safety of Pimavanserin for Parkinson's Disease and Efforts to Reduce Antipsychotics for People With Dementia. Schneider LS. Am J Psychiatry 2022;179:519-521.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schneider LS. The Safety of Pimavanserin for Parkinson's Disease and Efforts to Reduce Antipsychotics for People With Dementia. Am J Psychiatry 2022;179:519-521.
PMID: 35921393